Options
Drug metabolism in microorganisms
Author(s)
Date Issued
2015-01
Date Available
2016-06-20T15:59:13Z
Abstract
Several wild type and recombinant microorganisms can transform drugs to the equivalent human metabolites. Fungi, such as Cunninghamella spp., and Streptomyces bacteria express cytochrome P450 (CYP) enzymes that enable analogous phase I (oxidative) reactions with a wide range of drugs. The gene encoding the bifunctional CYP102A1 in Bacillus megaterium can be expressed easily in E. coli, and extensive mutagenesis experiments have generated numerous variants that can produce human drug metabolites. Additionally, human CYP isoforms have been expressed in various hosts. The application of microbial CYPs to the production of human drug metabolites is reviewed, and additional applications in the field of drug development are considered.
Type of Material
Journal Article
Publisher
Springer
Journal
Biotechnology Letters
Volume
37
Issue
1
Start Page
19
End Page
28
Copyright (Published Version)
2014 Springer Science+Business Media Dordrecht
Language
English
Status of Item
Peer reviewed
This item is made available under a Creative Commons License
File(s)
No Thumbnail Available
Name
BILE_Drug_Metabolism_in_Microorganisms_Final_Copy.docx
Size
417.23 KB
Format
Microsoft Word
Checksum (MD5)
ef96b65ea854ce363baec05af1c714f4
Owning collection